Teva CEO Francis becomes highest paid TASE co exec
The compensation cost of Teva Pharmaceutical Industries (NYSE: TEVA; TASE: TEVA) CEO Richard Francis totaled $25.7 million in 2023 (NIS 96.6 million at the current exchange rate). Most of the cost, $19 million, was in the form of stock-based compensation …